Bayesian Capital Management’s Cambrex Corporation CBM Stock Holding History

Bayesian Capital Management’s Portfolio CBM Stock Details CBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,826	Closed	-$585K	–	821
2019 Q3	$585K	Buy	+9,826	New	+$526K	0.11%	241
2017 Q2	–	Sell	-6,200	Closed	-$341K	–	658
2017 Q1	$341K	Sell	6,200 -3,800	-38%	-$203K	0.16%	236
2016 Q4	$540K	Buy	+10,000	New	+$480K	0.13%	292
2016 Q2	–	Sell	-6,276	Closed	-$276K	–	601
2016 Q1	$276K	Buy	+6,276	New	+$247K	0.26%	178

Other funds holding CBM

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Bayesian Capital Management's CBM Position: Q4 2019 in Review

Bayesian Capital Management sold out of Cambrex Corporation (CBM) in Q4 2019, closing a stake of 9,826 shares — an estimated $585K sold.

Bayesian Capital Management first reported a position in CBM in Q1 2016 and held it in 4 quarters. The position peaked at $585K in Q3 2019. 1 fund tracked by Wall St. Rank holds CBM as of Q4 2019.

Bayesian Capital Management reported no remaining Cambrex Corporation position as of Q4 2019 after selling out during the quarter.
Bayesian Capital Management sold 9,826 Cambrex Corporation shares in Q4 2019, an estimated $585K.
Bayesian Capital Management first reported a position in Cambrex Corporation in Q1 2016 and held it in 4 quarters.
Bayesian Capital Management's Cambrex Corporation position peaked at $585K in Q3 2019.
1 fund tracked by Wall St. Rank held Cambrex Corporation as of Q4 2019.

Based on Bayesian Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.